Healthcare entity
Every one of those 1 sits in a single category, market-trends. GeneDx is most often covered alongside Freightos, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Healthcare story that mention GeneDx, all published on February 21, 2026.
Last mentioned: Feb 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. GeneDx is most often covered alongside Freightos, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Healthcare story that mention GeneDx, all published on February 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GeneDx. Shared-story counts are live from our verified record — not editorial picks.
GeneDx and PepGen are scheduled to report quarterly financial results on Monday, marking a pivotal moment for the genomic diagnostics and neuromuscular biotech sectors. Investors are looking for GeneDx's continued path toward profitability through whole genome sequencing and PepGen's clinical pipeline progress.
GeneDx is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
